BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2982703)

  • 1. Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma.
    Qvigstad E; Onsrud M; Degré M; Skaug K
    Gynecol Oncol; 1985 Feb; 20(2):184-9. PubMed ID: 2982703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the cervix stage IB: numbers and reactivities of pelvic lymph node T cells.
    Onsrud M; Qvigstad E
    Gynecol Oncol; 1985 Feb; 20(2):177-83. PubMed ID: 2982702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
    Smith JW; Torres JE; Holmquist ND
    Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
    Meng XJ
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):108-10. PubMed ID: 2553361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
    Seth P; Prakash SS; Ghosh D
    Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
    Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
    Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B; Espmark A
    Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
    Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
    Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.
    Paavonen J; Karunakaran KP; Noguchi Y; Anttila T; Bloigu A; Dillner J; Hallmans G; Hakulinen T; Jellum E; Koskela P; Lehtinen M; Thoresen S; Lam H; Shen C; Brunham RC
    Am J Obstet Gynecol; 2003 Nov; 189(5):1287-92. PubMed ID: 14634555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antigenicity and immunology of human cervical squamous cell carcinoma: a review.
    McCoy JP; Haines HG
    Am J Obstet Gynecol; 1981 Jun; 140(3):329-36. PubMed ID: 7018244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
    Seth P; Balachandran N
    Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSV 2-associated antigens in human cervical tissues before and after grafting in nude mice.
    Christenson B; Furgyik S
    Acta Obstet Gynecol Scand; 1983; 62(5):461-6. PubMed ID: 6320579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero.
    Adam E; Kaufman RH; Adler-Storthz K; Melnick JL; Dreesman GR
    Int J Cancer; 1985 Jan; 35(1):19-26. PubMed ID: 2981778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of monocytes in vitro in patients with carcinoma of the uterine cervix.
    Bjercke S; Onsrud M; Gaudernack G
    Acta Obstet Gynecol Scand; 1986; 65(6):619-24. PubMed ID: 3026137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis.
    Agrawal T; Vats V; Salhan S; Mittal A
    Clin Exp Immunol; 2007 Jun; 148(3):461-8. PubMed ID: 17493018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer.
    Aurelian L; Strnad BC
    Cancer Res; 1976 Feb; 36(2 pt 2):810-20. PubMed ID: 175945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.